ReviewFrontiers in immunology2023

The importance of biomarker development for monitoring type 1 diabetes progression rate and therapeutic responsiveness.

Maxwell J Fyvie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.